skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: THRA1 and D17S183 flank an interval of <4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21

Journal Article · · American Journal of Human Genetics; (United States)
OSTI ID:6083140
;  [1]; ; ; ; ;  [2]; ;  [3]
  1. Univ. of Texas Southwestern Medical Center, Dallas (United States)
  2. Univ. of California, Berkeley (United States)
  3. Imperial Cancer Research Fund, London (United Kingdom)

In order to pinpoint the locale of the gene for early-onset familial breast and ovarian cancer (BRCA1), polymorphisms were developed within the locus for thyroid hormone receptor alpha (THRA1) and for several anonymous sequences at chromosome 17q12-q21. The THRA1 polymorphism is a dinucleotide repeat with 10 alleles and heterozygosity .79. Gene mapping in extended families with inherited, early-onset breast and ovarian cancer indicates that BRCA1 is distal to THRA1 and proximal to D17S183 (SCG43), an interval of <4 cM. This locale excludes HER2, THRA1, WNT3, HOX2, NGFR, PHB, COLIA1, NME1, and NME2 as candidates for BRCA1 but does not exclude RARA or EDH17B. Resolving the remaining recombination events in these families by new polymorphisms in the THRA1-D17S183 interval will facilitate positional cloning of the breast-ovarian cancer gene on chromosome 17q12-q21. 16 refs., 3 figs., 1 tab.

OSTI ID:
6083140
Journal Information:
American Journal of Human Genetics; (United States), Vol. 52:4; ISSN 0002-9297
Country of Publication:
United States
Language:
English